TY - JOUR
T1 - Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)
AU - Li, Q.
AU - Xiang, Y.T.
AU - Su, Y.A.
AU - Shu, L.
AU - Yu, X.
AU - Correll, C.U.
AU - Ungvari, Gabor
AU - Chiu, H.F.K.
AU - Ma, C.
AU - Wang, G.H.
AU - Bai, P.S.
AU - Li, T.
AU - Sun, L.Z.
AU - Shi, J.G.
AU - Chen, X.S.
AU - Mei, Q.Y.
AU - Li, K.Q.
AU - Si, T.M.
AU - Kane, J.M.
PY - 2015
Y1 - 2015
N2 - © 2015 Elsevier B.V. Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China. Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide were interviewed in 2002, 2006 and 2012. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects, satisfaction with treatment and quality of life (QOL) were recorded in a standardized fashion. Results: Clozapine was used in 32.9% of the whole sample; with corresponding figures of 39.7%, 32.5% and 26.4% in 2002, 2006 and 2012 (p2=0.498, p
AB - © 2015 Elsevier B.V. Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China. Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide were interviewed in 2002, 2006 and 2012. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects, satisfaction with treatment and quality of life (QOL) were recorded in a standardized fashion. Results: Clozapine was used in 32.9% of the whole sample; with corresponding figures of 39.7%, 32.5% and 26.4% in 2002, 2006 and 2012 (p2=0.498, p
U2 - 10.1016/j.schres.2015.07.048
DO - 10.1016/j.schres.2015.07.048
M3 - Article
C2 - 26277534
SN - 0920-9964
VL - 168
SP - 523
EP - 529
JO - Schizophrenia Research
JF - Schizophrenia Research
IS - 1-2
ER -